lymphoma

(redirected from T-cell lymphomas)
Also found in: Thesaurus, Medical, Encyclopedia.

lym·pho·ma

 (lĭm-fō′mə)
n. pl. lym·pho·ma·ta (-mə-tə) or lym·pho·mas
1. Any of various malignant tumors that arise from the lymphocytic cells of the immune system.
2. Any of various cancers characterized by the development of such tumors, especially Hodgkin lymphoma and non-Hodgkin lymphoma.

lym·pho′ma·toid′, lym·pho′ma·tous (-təs) adj.

lymphoma

(lɪmˈfəʊmə)
n, pl -mata (-mətə) or -mas
(Pathology) any form of cancer of the lymph nodes. Also called: lymphosarcoma
lymˈphomatous, lymˈphomaˌtoid adj

lym•pho•ma

(lɪmˈfoʊ mə)

n., pl. -mas, -ma•ta (-mə tə)
a tumor arising from any of the cellular elements of lymph nodes.
[1870–75]
lym•pho′ma•toid`, adj.

lymphoma

a growth of lymphoid tissue that is commonly cancerous and typically enlarges the lymph nodes.
See also: Cancer
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.lymphoma - a neoplasm of lymph tissue that is usually malignant; one of the four major types of cancer
cancer, malignant neoplastic disease - any malignant growth or tumor caused by abnormal and uncontrolled cell division; it may spread to other parts of the body through the lymphatic system or the blood stream
Hodgkin's disease - a malignant disorder in which there is progressive (but painless) enlargement of lymph tissue followed by enlargement of the spleen and liver
Translations
lymfom

lym·pho·ma

n. linfoma, neoplasma del tejido linfático.

lymphoma

n linfoma m; B cell — linfoma de células B; Hodgkin’s — linfoma (de) Hodgkin; mucosa-associated lymphoid tissue (MALT) — linfoma MALT, linfoma de tejido linfoide asociado a mucosas; non-Hodgkin’s — linfoma no Hodgkin; T cell — linfoma de células T
References in periodicals archive ?
T-cell lymphomas account for around one in 10 cases of lymphoma.
T-cell lymphoma from aggressive T-cell lymphomas with a cytotoxic [CD8.
Global Markets Direct's, 'Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2016', provides an overview of the Peripheral T-Cell Lymphomas (PTCL) pipeline landscape.
USPRwire, Tue Oct 27 2015] Global Markets Direct's, 'Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H2 2015', provides an overview of the Peripheral T-Cell Lymphomas (PTCL)'s therapeutic pipeline.
Primary cutaneous T-cell lymphomas (CTCLs) are a heterogeneous group of lymphomas that maybe present in the skin without any evidence of extracutaneous disease at the time of diagnosis [1, 2].
Primary small intestinal lymphomas account for 20-40% of primary GI tract lymphomas in western populations with survival data indicating that T-cell lymphomas carry the worst prognosis.
The 200 cases of non-Hodgkin's lymphoma included 118 T-cell lymphomas, 30 B-cell lymphomas, and 52 indeterminate types.
Withal it is a useful book, and having the less often discussed associations such as T-cell lymphomas and leiomyosarcomas assigned a place alongside authoritative chapters on the classic associations, nasopharyngeal carcinoma and Burkitt lymphoma, is convenient.
Fourteen samples (10 skin and 4 lymph node samples) had histologic and immunohistochemical evidence of malignancy (T-cell lymphomas), whereas 4 were benign lesions, despite the fact that they were from patients with T-cell lymphomas.
Recombinant human interleukin-12 induces lesion regression in some cutaneous T-cell lymphomas, reported Dr.
The standard front-line regimen for patients with mature T-cell lymphomas is a combination chemotherapy regimen, CHOP, that has demonstrated complete remission rates of 39 to 53 percent, with a 5-year overall survival rate of less than 50 percent," said Michelle Fanale, M.
These include the ECHELON-1 trial in frontline classical Hodgkin lymphoma from which positive top-line results were recently reported, the ongoing ECHELON-2 trial in frontline mature T-cell lymphomas, the completed ALCANZA trial in cutaneous T-cell lymphoma that supported a recent supplemental BLA to the FDA, and the recently initiated trial of Adcetris in combination with Opdivo (nivolumab) for relapsed/refractory Hodgkin lymphoma.